Johnson & Johnson has issued another Duragesic patch recall for one lot of their name brand pain patch and one lot of generic fentanyl patch which were sold by Sandoz, Inc. The fentanyl lawyers at Saiontz & Kirk, P.A. are investigating potential Duragesic patch lawsuits on behalf of users or… Read more.

In the first four Duragesic patch lawsuits to go to trial against two Johnson & Johnson subsidiaries, the plaintiffs have won every case and juries have returned verdicts which combine to exceed $36 million. >>INFORMATION: Duragesic Patch Problems

For the fourth time this year, a generic fentanyl pain patch recall was issued because some patches have been found to be leaking fentanyl gel, which could cause a fentanyl overdose or death. The latest recall was issued by Watson Pharmaceuticals, Inc. for one lot of their 75 mcg/hr Fentanyl… Read more.

Cephalon, Inc. is attempting to seek FDA approval for Fentora tablets to be used for sudden pain in non-cancer patients who have already developed a tolerance to opioids. An FDA advisory panel is scheduled to meet on Tuesday to review the subject. Documents released in advance of the meeting indicate… Read more.

For the third time in less than a month, a fentanyl patch recall has been issued due to fears that manufacturing defects could allow the powerful medication contained in the patch to leak directly onto the skin. This could cause respiratory depression, a fentanyl overdose or death. Millions of potentially… Read more.

Two fentanyl patch recalls have been issued over the past seven days due to a risk that users or handlers of the powerful painkiller could experience respiratory depression or fentanyl overdose after coming into contact with the patch. Two different manufacturing defects at different plants have resulted in recalls involving… Read more.

Yesterday, Johnson & Johnson issued a Duragesic recall for all lots of their 25 microgram-per-hour fentanyl patches. Some of the powerful painkilling patches could contain a cut in the lining of the internal reservoir where the fentanyl gel is stored. This may allow the gel to leak directly onto the… Read more.

Last month the FDA issued a second warning about Duragesic patch dangers which have claimed the lives of many people who never should have been given the powerful narcotic painkiller. Despite knowledge of these risks, Johnson & Johnson, the manufacturer of the Duragesic patch, continues to fail to take steps… Read more.

The FDA has issued a second warning about problems associated with the fentanyl pain patch. The powerful drug, which has been on the market since 1990, continues to result in unnecessary overdoses and deaths, especially when it is used inappropriately. Despite an earlier warning issued over two years ago, fentanyl… Read more.

The FDA issued a public health notice yesterday about the risk of death associated with the use of Fentora tablets.  Side effects could result in overdose or death caused by inappropriate use and over-prescription.  The manufacturer, Cephalon, Inc., has agreed to add stronger warnings and improve the dosing instructions to… Read more.